Kineticos Life Sciences

Kineticos is a life sciences investment firm that partners with companies to help improve patient outcomes. Its team brings together operators, executives, scientists, and investors with scientific, business, and operational expertise, along with experience supporting companies through different stages of growth. Kineticos invests across the life sciences ecosystem, including specialized pharmaceutical services, tools, and equipment, and provides portfolio companies with industry insight and access to a network of proven experts.

The firm’s funds focus on distinct areas of need. Kineticos Capital Partners backs companies serving the life sciences sector, while its Disruptor Funds support technologies aimed at advancing treatments for cancer, neurodegenerative diseases, and rare diseases. The Kineticos AMR Accelerator Fund invests in early-stage innovators working to address antimicrobial resistance. Through these investment strategies, Kineticos seeks high-growth opportunities and supports management teams throughout the business life cycle. The firm also shares portfolio updates, company news, and press releases, and invites prospective partners to contact its team to explore collaboration.